|
 |
|
 |
 |
Currently, there are no medications that cure food allergies. Strict avoidance is the only way to prevent a reaction. Most people outgrow their food allergies, although peanuts, nuts, fish, and shellfish are often considered lifelong allergies. Some research is being done in this area and it looks promising. Click here for research information.
|
|
|
|
 |
The size of the epinephrine self-injector market is estimated to be roughly $215 million or 4.1 million patients with a 20-25% growth rate. These estimates are derived from the number of people at risk for anaphylaxis, the size of the patient population, the expiration life of epinephrine and the number of epinephrine self-injector units sold in 2002. The following are the details behind our market calculations.
First, epinephrine self-injection devices must be prescribed by a physician. Studies indicate that patients who are susceptible to anaphylaxis are prescribed an average of two injectors. Also, epinephrine medication expires and requires replacement every two years. In addition, the number of units sold in 2002 was 2.5 million, and based on the number of doses suggested per episode and the number of units actually sold in 2002 the patient population in 2002 is estimated to be 2.8 million. Finally, it is estimated that the patient population is growing at the same rate as the injector market, 10-15%.
|
|
|
 |
|
Market Segmentation
Target Market
